Search Results - "Castro Malaspina, H"

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease by PERALES, M.-A, ISHILL, N, JAKUBOWSKI, A. A, O'REILLYL, R. J, SMALL, T. N, YOUNG, J. W, KERNAN, N. A, LOMAZOW, W. A, WEINSTOCK, D. M, PAPADOPOULOS, E. B, DASTIGIR, H, CHIU, M, BOULAD, F, CASTRO-MALASPINA, H. R, HELLER, G

“…Daclizumab has been shown to have activity in acute GVHD, but appears to be associated with an increased risk of infection. To investigate further the…”
Get full text

Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation by Avery, S, Voss, M H, Gonzales, A M, Lubin, M, Castro-Malaspina, H, Giralt, S, Kernan, N A, Scaradavou, A, Hedvat, C V, Stevens, C E, Barker, J N

“…Delayed or failed engraftment remains a concern after cord blood transplantation (CBT) even when using double-unit grafts. Therefore, we analyzed the…”
Get full text

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT by Perales, M-A, Jenq, R, Goldberg, J D, Wilton, A S, Lee, S S E, Castro-Malaspina, H R, Hsu, K, Papadopoulos, E B, van den Brink, M R M, Boulad, F, Kernan, N A, Small, T N, Wolden, S, Collins, N H, Chiu, M, Heller, G, O'Reilly, R J, Kewalramani, T, Young, J W, Jakubowski, A A

“…T-cell depleted allogeneic hematopoietic SCT (TCD-HSCT) have shown durable disease-free survival with a low risk of GVHD in patients with AML. We investigated…”
Get full text

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants by Goldberg, J D, Zheng, J, Castro-Malaspina, H, Jakubowski, A A, Heller, G, van den Brink, M R M, Perales, M-A

“…Palifermin, a recombinant human keratinocyte growth factor, is commonly given to prevent mucositis following autologous transplantation. In the allogeneic…”
Get full text

Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT by Ceberio, I, Dai, K, Devlin, S M, Barker, J N, Castro-Malaspina, H, Goldberg, J D, Giralt, S, Adel, N G, Perales, M-A

“…Antifungal prophylaxis with azoles is considered standard in allogeneic hematopoietic SCT (allo-HSCT). Although sirolimus is being used increasingly for the…”
Get full text

Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era by Mussetti, A, Devlin, S M, Castro-Malaspina, H R, Barker, J N, Giralt, S A, Zelenetz, A D, Sauter, C S, Perales, M-A

“…Relapsed and refractory (rel/ref) mantle cell lymphoma (MCL) portend a dismal prognosis. Allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
Get full text

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation by Hobbs, G S, Kaur, N, Hilden, P, Ponce, D, Cho, C, Castro-Malaspina, H R, Giralt, S, Goldberg, J D, Jakubowski, A A, Papadopoulos, E B, Sauter, C, Koehne, G, Yahalom, J, Delvin, S, Barker, J N, Perales, M-A

Get full text

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis by Cho, C, Hsu, M, Barba, P, Maloy, M A, Avecilla, S T, Barker, J N, Castro-Malaspina, H, Giralt, S A, Jakubowski, A A, Koehne, G, Meagher, R C, O’Reilly, R J, Papadopoulos, E B, Ponce, D M, Tamari, R, van den Brink, M R M, Young, J W, Devlin, S M, Perales, M-A

“…CD34+ cell selection significantly improves GvHD-free survival in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, specific information…”
Get full text

Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS by Dahi, P B, Morawa, E, Perales, M-A, Zabor, E C, Devlin, S M, Maloy, M, Castro-Malaspina, H, O'Reilly, R J, Papadopoulos, E B, Jakubowski, A A, Giralt, S A

Get full text

Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions by Small, T.N., Papadopoulos, E.B., Boulad, F., Black, P., Castro-Malaspina, H., Childs, B.H., Collins, N., Gillio, A., George, D., Jakubowski, A., Heller, G., Fazzari, M., Kernan, N., MacKinnon, S., Szabolcs, P., Young, J.W., O’Reilly, R.J.

“…Unrelated bone marrow transplantation (BMT) is often complicated by fatal opportunistic infections. To evaluate features unique to immune reconstitution after…”
Get full text

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation : Effect of patient age and donor leukocyte infusions by SMALL, T. N, PAPADOPOULOS, E. B, HELLER, G, FAZZARI, M, KERNAN, N, MACKINNON, S, SZABOLCS, P, YOUNG, J. W, O'REILLY, R. J, BOULAD, F, BLACK, P, CASTRO-MALASPINA, H, CHILDS, B. H, COLLINS, N, GILLIO, A, GEORGE, D, JAKUBOWSKI, A

“…Unrelated bone marrow transplantation (BMT) is often complicated by fatal opportunistic infections. To evaluate features unique to immune reconstitution after…”
Get full text

86 ALLOGENEIC TRANSPLANTATION FOR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL EVEN IN THE SETTING OF HIGH-RISK DISEASE by Sanchez, M, Abbi, K, Tamari, R, Jakubowski, A, Papadopoulos, E, Devlin, S, Sauter, C, Barker, J.N, Boulad, F, Giralt, S, Meagher, R, Castro-Malaspina, H

Get full text

16 OUTCOMES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME RECEIVING EX-VIVO T-CELL DEPLETED OR UNMODIFIED ALLOGRAFTS: COMPARISON OF RESULTS AT TWO INSTITUTIONS by Tamari, R, Oran, B, Hilden, P, Papadopoulos, E, Kongtim, P, Rondon, G, Jakubowski, A, Anderssson, B, Devlin, S, Ahmed, S, Young, J, Popat, U, Chen, J, De Lima, M, O'Reilly, R, Giralt, S, Champlin, R, Castro-Malaspina, H

Get full text

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma by Gulati, S C, Shank, B, Black, P, Yopp, J, Koziner, B, Straus, D, Filippa, D, Kempin, S, Castro-Malaspina, H, Cunningham, I

“…Review of prognostic factors at Memorial Hospital in New York City has shown that adult patients with large-cell lymphoma (diffuse histiocytic lymphoma by…”
Get more information

Adoptive Immunotherapy Evaluating Escalating Doses of Donor Leukocytes for Relapse of Chronic Myeloid Leukemia After Bone Marrow Transplantation: Separation of Graft-Versus-Leukemia Responses From Graft-Versus-Host Disease by Mackinnon, Stephen, Papadopoulos, Esperanza B., Carabasi, Matthew H., Reich, Lilian, Collins, Nancy H., Boulad, Farid, Castro-Malaspina, Hugo, Childs, Barrett H., Gillio, Alfred P., Kernan, Nancy A., Small, Trudy N., Young, James W., O'Reilly, Richard J.

“…Infusions of large numbers (>108/kg) of donor leukocytes can induce remissions in patients with chronic myeloid leukemia (CML) who relapse after marrow…”
Get full text

Posterior reversible encephalopathy syndrome due to sirolimus by Moskowitz, A, Nolan, C, Lis, E, Castro-Malaspina, H, Perales, M-A

Get full text

P-219 T cell depleted (TCD) allogeneic hematopoietic stem cell transplant for older patients with advanced MDS and AML evolved from MDS by Tamari, R, Chung, S, Devlin, S, Jakubowski, A, Papadopoulos, E, Perales, M.A, Ponce, D, Goldberg, J, Barker, J, Sauter, C, Koehne, G, Young, J, Giralt, S, Castro-Malaspina, H

Get full text

P-221 Characteristic of relapse after T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced MDS by Tamari, R, Chung, S, Devlin, S, Jakubowski, A, Papadopoulos, E, Boulad, F, Small, T, Kernan, N, Ponce, D, Sauter, C, Young, J, Giralt, S, O'Reilly, R, Castro-Malaspina, H

Get full text

Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation by AMSTERDAM, A, JAKUBOWSKI, A, CASTRO-MALASPINA, H, BAXI, E, KAUFF, N, KRYCHMAN, M, STIER, E, CASTIEL, M

“…The management of uterine bleeding in female transplant patients over a 3-year period at our institution was reviewed. A total of 33 females who had undergone…”
Get full text

Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones by ARATEN, D. J, BESSLER, M, MCKENZIE, S, CASTRO-MALASPINA, H, CHILDS, B. H, BOULAD, F, KARADIMITRIS, A, NOTARO, R, LUZZATTO, L

“…PNH is characterized by expansion of one or more stem cell clones with a PIG-A mutation, which causes a severe deficiency in the expression of…”
Get full text